Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Condition:   Epidermolysis Bullosa Dystrophica, Recessive Intervention:   Biological: COL7A1-SIN retroviral vector engineered autologous tissue-engineered skin Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials